XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue        
Revenues $ 529 $ 1,339 $ 13,032 $ 4,597
Operating expenses        
Research and development 5,778 14,273 20,235 45,227
General and administrative 3,044 4,537 12,204 17,396
Change in fair value of contingent consideration 268 344 827 735
Restructuring costs 98 3,625 12,636 3,625
Total operating expenses 9,188 22,779 45,902 66,983
Loss from operations (8,659) (21,440) (32,870) (62,386)
Interest income 952 1,747 3,191 5,121
Interest expense (23) (29) (79) (107)
Foreign exchange (loss) gain (12) 5 13 (16)
Total other income 917 1,723 3,125 4,998
Net loss $ (7,742) $ (19,717) $ (29,745) $ (57,388)
Net loss per common share        
Basic (in USD per share) $ (0.04) $ (0.10) $ (0.16) $ (0.31)
Diluted (in USD per share) $ (0.04) $ (0.10) $ (0.16) $ (0.31)
Weighted average number of common shares        
Basic (in shares) 191,778,950 188,997,194 191,347,969 184,244,819
Diluted (in shares) 191,778,950 188,997,194 191,347,969 184,244,819
Comprehensive loss        
Unrealized gain on available-for-sale securities $ 58 $ 218 $ 6 $ 331
Comprehensive loss (7,684) (19,499) (29,739) (57,057)
Collaborations and licenses        
Revenue        
Revenues 280 767 11,809 2,861
Non-cash royalty revenue        
Revenue        
Revenues $ 249 $ 572 $ 1,223 $ 1,736